|
J&J Sees Little Growth in 2Q; Synthes Integration a Priority
Johnson & Johnson’s Synthes acquisition closed less than two weeks before the end of the 2012 second quarter, but the division still contributed 1.2 percent to J&J’s worldwide operational sales growth.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives